期刊文献+

槲皮素三元自组装纳米胶束的制备及表征

Preparation and Characterization of Ternary Self-assembled Nanomicelles of Quercetin
原文传递
导出
摘要 目的制备槲皮素纳米胶束,用以改善其溶解度。方法以磷脂/胆盐/聚乙烯吡咯烷酮为载体材料,采用薄膜分散法制备槲皮素三元纳米胶束,对其处方及制备工艺进行筛选优化,并对制备的纳米胶束进行表征与评价。结果优选出的最佳制备处方及工艺为槲皮素37.5 mg,大豆磷脂150 mg,脱氧胆酸钠225 mg,聚乙烯吡咯烷酮K3060 mg置于圆底烧瓶中,加入适量体积分数95%乙醇,超声溶解,45℃减压旋转蒸发25 min去除有机溶剂,加入生理盐水15 mL,超声120 s匀速振摇水化脱膜,12000 r·min^(-1)离心5min去除未包封药物,即得澄清槲皮素胶束溶液。槲皮素纳米胶束呈类球形,粒径为(8.0±0.5)nm,PDI为(0.153±0.06),Zeta电位为(-32.4±0.155)mV,药物包封率为(82.83±7.34)%,含量为(2.07±0.03)mg·mL^(-1)。槲皮素纳米胶束具有良好稳定性,6个月内外观、粒径、含量无明显变化。72 h药物体外释放达到67%左右。结论本研究的优选处方及工艺可以用于槲皮素纳米胶束的制备,其溶解度提高约750倍。 OBJECTIVE To prepare quercetin nanomicelles and improve its solubility.METHODS Using phospholipid,bile salt and polyvinylpyrrolidone as carrier materials,quercetin ternary nanomicelles were prepared by thin film dispersion method.The formulation and preparation process were screened and optimized,and the prepared nanomicelles were characterized and evaluated.RESULTS The optimal preparation formula and process were as follows:firstly,put quercetin 37.5 mg,soybean phospholipids 150 mg,Sodium deoxycholate 225 mg,and polyvinylpyrrolidone K3060 mg in a round-bottom flask.Secondly,It has been added an appropriate amount of 95%ethanol and dissolved by ultrasound.Thirdly,the solution was evaporated at 45℃for 25 min to remove the organic solvent.At last,15 mL of normal saline was added,and the membrane was decoated by ultrasonic 120 s shaking at a constant speed.The unencapsulated drug was removed by centrifugation at 12000 r·min^(-1)for 5 min,and the quercetin micellar solution was clarified.Quercetin micelles showed regular spherical shapes.The particle size was(8.0±0.5)nm,the polydispersity index(PDI)was(0.153±0.06),the Zeta potential was(-32.4±0.155)mV,the encapsulation efficiency was(82.83±7.34)%,the content of the drug was(2.07±0.03)mg·mL^(-1)and the drug release in vitro reached about 67%after 72 h.Quercetin nanomicelles had good stability and no obvious change in appearance,particle size and content within 6 months.CONCLUSION The process can be used for the preparation of quercetin nanomicelles,and the solubility of quercetin is increased by about 750 times.
作者 何朝星 孙玉林 贾佳 郝俊红 刘砚 敦洁宁 杜青 HE Chao-xing;SUN Yu-lin;JIA-Jia;HAO Jun-hong;LIU Yan;DUN Jie-ning;DU Qing(School of Pharmacy,Hebei Medical University,Shijiazhuang 050017,China;Department of Pharmacy,the Third Hospital of Hebei Medical University,Shijiazhuang 050000,China)
出处 《中国药学杂志》 CAS CSCD 北大核心 2022年第22期1911-1916,共6页 Chinese Pharmaceutical Journal
基金 河北省自然科学基金项目资助(H2018206052,H2020206451) 河北省2021年度医学科学研究课题资助(20211108)。
关键词 槲皮素 纳米胶束 溶解度 薄膜分散法 quercetin nanomicelle solubility thin film dispersion method
  • 相关文献

参考文献10

二级参考文献97

  • 1吴顺芹,李三鸣,郎轶咏,刘华,刘洪卓.水包油型微乳形成因素的考察[J].沈阳药科大学学报,2005,22(2):96-99. 被引量:21
  • 2Ikemoto S, Sugimura K, Kuratukuri K, et al. Antitumor effects of lipoxygenase inhibitors on murine bladder cancer cell line (MBT-2) [J]. Anticancer Res, 2004, 24(2B): 733-738. 被引量:1
  • 3Wang N, Tang L J, Zhu G Q. Apoptosis induced by baicalin involving up-regulation of P53 and bax in MCF-7 cells [J]. JAsian Prod Res, 2008, 10(11/12): 1129-1235. 被引量:1
  • 4Chen J, Li Z, Chen A Y. Inhibitory effect of baicalin and baicalein on ovarian cancer cells [J]. Int JMol Sci, 2013, 14(3): 6012-6025. 被引量:1
  • 5Wang X F, Zhou Q M, Du J. Baicalin suppresses migration, invasion and metastasis of breast cancer via p38MAPK signaling pathway [J]. Anticancer Agents Med Chem, 2013, 13(6): 923-931. 被引量:1
  • 6Liu Z D, Zhang X H, Wu H Y, et al. Preparation and evaluation of solid lipid nanoparticles of BCN for ocular drug delivery system in vitro and in vivo [J]. Drug Dev IndPharm, 2011, 37(4): 475-481. 被引量:1
  • 7Chen Y J, Jia Y, Jin R X, et al. Preparation of BCN flexible nano-liposomes [J]. Chin J Exp Tradit Med Formula, 2011, 17(5): 1-4. 被引量:1
  • 8Wang C, Zhao X M, Hao J F, et al. The process on new technology and novel dosage form to improve the bioavailability of BCN [J]. Chin Tradit Pat Med, 2012, 34(3): 545-549. 被引量:1
  • 9Mikhail A S, Allen C. Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels [J]. J Controlled Release, 2009, 138(3): 214-223. 被引量:1
  • 10Nishiyama N, Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery [J]. Pharmacol Therapeut, 2006, 112(3): 630-648. 被引量:1

共引文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部